ArticleBMC pulmonary medicine2026
A study of excessive dynamic airway collapse in chronic obstructive pulmonary disease patients.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExcessive dynamic airway collapse (EDAC) is defined as a pathological expiratory reduction of ≥ 50% in the cross-sectional area of the tracheobronchial lumen due to increased laxity of the posterior membranous wall while preserving the cartilaginous structure. EDAC frequently coexists with chronic obstructive pulmonary disease (COPD) and may contribute to persistent wheezing and dyspnea despite optimal medical therapy.
methodsThis cross-sectional study included 75 stable COPD patients recruited from the outpatient clinic of the Chest Department, Faculty of Medicine, Tanta University Hospitals, between August 2024 and August 2025. All patients underwent detailed history taking, general and local clinical examination, spirometry, dynamic multidetector computed tomography (MDCT) of the chest, and fiberoptic bronchoscopy. Multivariate logistic regression analysis was performed to identify predictors of EDAC.
resultsEDAC was identified in 29 (38.7%) out of 75 COPD patients based on bronchoscopic assessment. Among these 29 patients, dynamic chest CT successfully diagnosed EDAC in 27 cases, resulting in 93.1% (95% CI: 77.2-99.2) sensitivity, 100% (95% CI: 92.3-100.0) specificity, and 97.3% (95% CI: 90.1-100.0) diagnostic accuracy. COPD patients with EDAC showed significantly higher BMI, mMRC, CAT scores, and exacerbation frequency compared with those without EDAC. Conversely, patients with COPD and EDAC showed significantly lower FEV1% predicted and FVC% predicted compared with those without EDAC. BMI, mMRC, and CAT score were independent predictors of EDAC.
conclusionsEDAC should be evaluated in all COPD patients who present with more symptoms despite optimal COPD management. Also, obesity in COPD patients represents a contributing factor for EDAC, which should be carefully evaluated and managed. Dynamic CT demonstrated good diagnostic performance in detecting EDAC when compared with bronchoscop.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.